355-潘氏样分化驱动结直肠癌耐药 episode artwork

EPISODE · Jan 3, 2026 · 19 MIN

355-潘氏样分化驱动结直肠癌耐药

from 聊聊Sci

这项研究揭示了结直肠癌(CRC)在接受KRAS与EGFR联合靶向治疗时,会通过一种非遗传性的谱系可塑性机制产生耐药性。研究人员发现,存活的癌细胞会向类潘氏细胞(Paneth-like)状态转变,从而逃避药物杀伤,且这一现象在小鼠模型、类器官及临床患者样本中均得到了验证。通过CRISPR筛选和转录组分析,研究确认了SMAD1-FGFR3信号轴是驱动这种细胞状态转换及MAPK信号通路重新激活的关键因素。研究进一步证明,利用FGFR抑制剂(如futibatinib)阻断该轴线,可以有效抑制细胞向类潘氏状态转变并恢复药物敏感性。该成果为克服结直肠癌靶向治疗耐药提供了新的三联疗法策略。References: Zhang Y, Chen J, She Y, et al. Paneth-like transition drives resistance to dual targeting of KRAS and EGFR in colorectal cancer[J]. Cancer Cell, 2025.前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Jan 3, 2026

Embed this episode

Ready to play

355-潘氏样分化驱动结直肠癌耐药

0:00 19:04

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 19 minutes long.

When was this 聊聊Sci episode published?

This episode was published on January 3, 2026.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!